Search Results - "Alzahrani, Hazzaa"

Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries by Aljurf, Mahmoud, Weisdorf, Daniel, Alfraih, Feras, Szer, Jeff, Müller, Carlheinz, Confer, Dennis, Hashmi, Shahrukh, Kröger, Nicolaus, Shaw, Bronwen E., Greinix, Hildegard, Kharfan-Dabaja, Mohamed A., Foeken, Lydia, Seber, Adriana, Ahmed, Syed, El-Jawahri, Areej, Al-Awwami, Moheeb, Atsuta, Yoshiko, Pasquini, Marcelo, Hanbali, Amr, Alzahrani, Hazzaa, Okamoto, Shinichiro, Gluckman, Eliane, Mohty, Mohamad, Kodera, Yoshihisa, Horowitz, Mary, Niederwieser, Dietger, El Fakih, Riad

“…Hematopoietic cell transplantation (HCT) activity is increasing at an unprecedented pace with > 50,000 allogeneic transplants occurring annually worldwide…”
Get full text

Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT) by ElGohary, Ghada, El Fakih, Riad, de Latour, Regis, Risitano, Antonio, Marsh, Judith, Schrezenmeier, Hubert, Gluckman, Eliane, Höchsmann, Britta, Pierri, Filomena, Halkes, Constantijn, Alzahrani, Hazzaa, De la Fuente, Josu, Cesaro, Simone, Alahmari, Ali, Ahmed, Syed Osman, Passweg, Jakob, Dufour, Carlo, Bacigalupo, Andrea, Aljurf, Mahmoud

“…Aplastic anemia (AA) is a serious hematological disorder, which is solely cured by hematopoietic stem cell transplantation (HSCT). Haploidentical HSCT is an…”
Get full text

Clinical and Demographic Characteristics of Pyruvate Kinase Deficiency Patients: A Comprehensive Case Series Analysis by Nasiri, Abdulrahman, Haroon, Alfadil, Alzahrani, Hazzaa

“…Introduction Pyruvate kinase deficiency (PKD) is a rare autosomal recessive disorder characterized by mutations in the PKLR gene, causing impaired glycolysis…”
Get full text

Plasminogen Deficiency: A Case Report and Review by Nasiri, Abdulrahman, Nassar, Marwa, Alzahrani, Hazzaa

“…Plasminogen deficiency, a rare disorder characterized by impaired fibrinolysis, frequently results in ligneous conjunctivitis. In this report, we report a case…”
Get full text

SUCCESSFUL MANAGEMENT OF SEVERE CONGENITAL FACTOR X DEFICIENCY DURING PREGNANCY AND LABOR WITH PCC IN TWO SISTERS by Alfadil Haroon, Riad Elfakih, Hazzaa Alzahrani

“…Introduction: Factor X (FX) deficiency is an autosomal recessive disorder caused by quantitative or qualitative defects in the FX protein. FX deficiency has an…”
Get full text

The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes by Nassani, Momen, Fakih, Riad El, Passweg, Jakob, Cesaro, Simone, Alzahrani, Hazzaa, Alahmari, Ali, Bonfim, Carmem, Iftikhar, Raheel, Albeihany, Amal, Halkes, Constantijn, Ahmed, Syed Osman, Dufour, Carlo, Aljurf, Mahmoud

“…Bone marrow failure syndromes are a heterogeneous group of diseases. With the major advancements in diagnostic tools and sequencing techniques, these diseases…”
Get full text

Allogeneic transplant compared to pediatric-inspired therapy for Philadelphia chromosome-negative adolescent and adult ALL in first complete remission by Haroon, Alfadil, Alfraih, Feras, Hanbali, Amr, Kotb, Ahmed, Somali, Zakiah Al, Bahkali, Fahad N., Alhayli, Saud, Madien, Heba Mahmoud, Ahmed, Syed Osman, Albabtain, Abdulwahab A., Shaheen, Marwan, Chaudhri, Naeem, Alsharif, Fahad, Alshaibani, Alfadel, Alotaibi, Ahmad S., Elhassan, Tusneem, Almohareb, Fahad, Alahmari, Ali, Rasheed, Walid, Alzahrani, Hazzaa, Aljurf, Mahmoud, El Fakih, Riad

“…Background Pediatric-inspired non-transplant regimens for adolescent and adult ALL patients are becoming standard in many institutions. We aimed to compare a…”
Get full text

P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE by Haroon, Alfadil, El Fakih, Riad, Aljurf, Mahmoud, Isam Sharif, Mohammed, Elhassan, Tusneem, Alzahrani, Hazzaa

Get full text

CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE by Al Raizah, Abdulrahman, Alayoubi, Fakhr, Abdelnaby, Galal Hassan, Alzahrani, Hazzaa, Bakheet, Majid Farraj, Alskaini, Mohammed A, Buhumaid, Rasha, Awadhi, Sameer Al, Kazim, Sara Nooruddin, Jaiganesh, Thiagarajan, Al Asiri, Zohair

“…Background: The non-vitamin K antagonist oral anticoagulants (NOACs) have become the mainstay anticoagulation therapy for patients requiring oral…”
Get full text

Genotype Hemophilia Screening Program Identified 2 Novel Variants Including a Novel Variant (c.5816-2A > G) Causing a Pathogenic Variant of the Factor 8 Gene by Owaidah, Tarek, Bakr, Salwa, Al-Numair, Nouf, AbaAlkhail, Hala, Alzahrani, Hazzaa, Saleh, Mahasen, Khogeer, Haitham, Tarawah, Ahmed, Akkad, Hadeel, Al-Allaf, Faisal

“…Establishing a national screening program for hemophilia patients is highly encouraged by the World Health Organization and the World Federation of Hemophilia…”
Get full text

Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia working party of the European Society for blood and marrow transplantation (SAAWP of EBMT) by Iftikhar, Raheel, Ahmad, Parvez, de Latour, Regis, Dufour, Carlo, Risitano, Antonio, Chaudhri, Naeem, Bazarbachi, Ali, De La Fuente, Josu, Höchsmann, Britta, Osman Ahmed, Syed, Gergis, Usama, Elhaddad, Alaa, Halkes, Constantijn, Albeirouti, Bassim, Alotaibi, Sultan, Kulasekararaj, Austin, Alzahrani, Hazzaa, Ben Othman, Tarek, Cesaro, Simone, Alahmari, Ali, Rihani, Rawad, Alshemmari, Salem, Hamidieh, Amir Ali, Bekadja, Mohamed-Amine, Passweg, Jakob, Al-Khabori, Murtadha, Rasheed, Walid, Bacigalupo, Andrea, Chaudhry, Qamar-Un-Nisa, Ljungman, Per, Marsh, Judith, El Fakih, Riad, Aljurf, Mahmoud

“…Aplastic anemia is a relatively rare but potentially fatal disorder, with a reported higher incidence in developing countries in comparison to the West. There…”
Get full text

Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts by El Fakih, Riad, Alfraih, Feras, Alhayli, Saud, Ahmed, Syed Osman, Shaheen, Marwan, Chaudhri, Naeem, Alsharif, Fahad, Hanbali, Amr, Alshaibani, Alfadel, Alotaibi, Ahmad S., Alharbi, Bander, AlYahya, Faisal Mohammed, Rawas, Wedian M., Ghabashi, Emad, Kotb, Ahmed, Elhassan, Tusneem, Rasheed, Walid, Alzahrani, Hazzaa, Almohareb, Fahad, Alahmari, Ali, Aljurf, Mahmoud

“…Priming donors with G-CSF before BM harvest is reported to improve engraftment and GvHD in recipients. These effects are highly desirable when transplanting…”
Get full text

Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT) by AlDawsari, Ghuzayel, Elhaddad, Alaa, El Fakih, Riad, Ben Othman, Tarek, Ahmed, Parvez, Ghavamzadeh, Ardeshir, Bazarbachi, Ali, Dasouki, Majed J., Fathy, Gamal, Alzahrani, Hazzaa, Samra, Mohamed, Torjemane, Lamia, Satti, Tariq Mahmood, Shaheen, Marwan, Alfraih, Feras, Ayas, Mouhab, Alahmari, Ali, Alhayli, Saud, Nassar, Amr, Abboud, Miguel, Abdelfattah, Raafat, El Solh, Hassan, Hashmi, Shahrukh, Elhassan, Tusneem, Ahmed, Syed Osman, Aljurf, Mahmoud

“…Hematopoietic Stem Cell Transplantation (HSCT) is the only potentially curative treatment option for the hematologic complications that occur in patients with…”
Get full text

Outcomes of allogeneic hematopoietic cell transplant for acute myeloid leukemia in adolescent patients by El Fakih, Riad, Kotb, Ahmed, Hashmi, Shahrukh, Chaudhri, Naeem, Alsharif, Fahad, Shaheen, Marwan, Alshomar, Ahmad, Hanbali, Amr, Alfraih, Feras, Alhayli, Saud, Albarqi, Hussein, Alnefaie, Budur, Elhassan, Tusneem, Alsadi, Husam, Youniss, Riad, Alahmari, Ali, Rasheed, Walid, Alzahrani, Hazzaa, Almohareb, Fahad, Ahmed, Syed, Aljurf, Mahmoud

“…Patients between 14 and 22 years old are underrepresented in both adult and pediatric studies. We analyzed the outcomes of 94 consecutive patients aged between…”
Get full text

ACQUIRED FACTOR XIII DEFICIENCY WITH RUNX1 MUTATION, A REPORT OF TWO CASES TREATED WITH FACTOR XIII CONCENTRATE by Alfadil Haroon, Ali Alahmari, Nadiah Alobaidi, Ahmed Syed Osman, Hazzaa Alzahrani

“…Acquired FXIII deficiency has been described in association with malignancies or autoimmune disorders. We report two cases of acquired FXIII deficiency…”
Get full text

OUTCOME OF APLASTIC ANEMIA ACCORDING TO DISEASE SEVERITY by Alfadil Haroon, Syed Osman Ahmed Ahmed, Hazzaa Alzahrani, Riad El Fakih, Ali Alahmari, Alfadel Alshaibani, Naeem Chaudhri, Fahad Almohareb, Saud Alhayli, Marwan Shaheen, Abdulwahab Albabtain, Fahad Alsharif, Feras Alfraih, Walid Rasheed, Mahmoud Aljurf

“…Objective Background: Aplastic anemia is pancytopenia with a hypocellular bone marrow [<25 % (or 25 to 50 % if <30 % of residual cells are hematopoietic)] due…”
Get full text

Assessing the Performance of Extended Half-Life Coagulation Factor VIII, FC Fusion Protein by Using Chromogenic and One-Stage Assays in Saudi Hemophilia A Patients by Aguilos, Amelita M., Alnosair, Abdulmjeed O., Al-Numair, Nouf S., Alzahrani, Hazzah, Owaidah, Tarek, Saleh, Mahasen

“…Background. The one-stage assay is the most common method to measure factor VIII activity (FVIII : C) in hemophilia A patients. The chromogenic assay is…”
Get full text

Thromboembolic Events Burden in Patients With Solid Tumors and Their Predisposing Factors by Bazarbashi, Shouki, Alkhaldi, Turkiah, Aseafan, Mohamed, Melaibari, Maryam, Almuhisen, Sara, Alharbi, Samar, Alghabban, Abdulrahman, Aljumaa, Jihad, Eldali, Abdelmoneim, Maraiki, Fatma, Owaidah, Tarek, Alzahrani, Hazzaa

“…The relationship between cancers and thromboembolic events is well established. In our study, we aim to determine the burden of thromboembolic events in…”
Get full text

Approaches to acquired thrombotic thrombocytopenic purpura management in Saudi Arabia by Ayman AlHejazi, Amal AlBeihany, Hani AlHashmi, Hazzaa Alzahrani, Ibraheem H Motabi, Ihab El-Hemaidi, Khalid Alsaleh, Khaled El Tayeb, Magdy Rabea, Mohamed Khallaf, Mohammad Hasan Qari

“…Acquired thrombotic thrombocytopenic purpura (aTTP) is a life-threatening microangiopathy usually characterized by microangiopathic hemolytic anemic,…”
Get full text

The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities by Hassanein, Mona, Fakih, Riad El, Rasheed, Walid, Ahmed, Syed, Shaheen, Marwan, Chaudhri, Naeem, Alsharif, Fahad, Ahmed, Shad, Hanbali, Amr, AlShaibani, Alfadel, Alfraih, Feras, Alhayli, Saud, Elhassan, Tusneem, Alahmari, Ali, Alzahrani, Hazzaa, Almohareb, Fahad, Aljurf, Mahmoud, Hashmi, Shahrukh

“…Secondary acute myeloid leukemia (sAML) includes AML as a complication of an antecedent hematological disorder or a therapy‐related AML. Large registry‐based…”
Get full text